Imipenem/Cilastatin Side Effects: What to Expect and When to Call Your Doctor

Imipenem/Cilastatin (Primaxin) is a powerful antibiotic that treats serious bacterial infections — but like any strong medication, it comes with a range of possible side effects. Knowing what to expect, what's normal, and what requires immediate medical attention can make your treatment much safer and less stressful. This guide covers both common and serious side effects of Imipenem/Cilastatin in plain language.

Common Side Effects of Imipenem/Cilastatin

Most patients tolerate Imipenem/Cilastatin reasonably well. These are the side effects you're most likely to experience:

• Nausea and vomiting: One of the most common side effects. Usually mild to moderate. Tell your nurse if this happens during an infusion — slowing the infusion rate sometimes helps.

• Diarrhea: Mild, loose stools are common with antibiotics. However, severe or bloody diarrhea could indicate C. difficile infection (see Serious Side Effects below).

• Injection site reactions: Pain, redness, or swelling at the IV insertion site (phlebitis) is common. Rotating IV sites helps. Report significant swelling or hardness to your nurse.

• Fever and chills: Sometimes occur during or shortly after infusion. May be difficult to distinguish from fever caused by your underlying infection. Report any new or worsening fever to your medical team.

• Dizziness or drowsiness: Some patients feel lightheaded or sleepy during treatment. Do not drive or operate heavy machinery if this affects you.

• Elevated liver enzymes: Transient, asymptomatic elevations in liver enzymes (AST, ALT) occur in approximately 6% of patients during a 5–14 day course. These typically resolve when treatment ends, but regular lab monitoring is recommended.

Serious Side Effects: Call Your Doctor Immediately If You Experience These

• Seizures: Imipenem is more likely to cause seizures than other carbapenems, especially at high doses or in patients with kidney disease, brain injury, or a history of seizures. Seizure rates as high as 6% have been reported when dosing is not carefully adjusted for renal function. Signs of an upcoming seizure may include muscle twitching, jerking, tremors, or uncontrolled movements. Call 911 immediately if a seizure occurs.

• C. difficile-associated diarrhea (CDAD): Like all broad-spectrum antibiotics, Imipenem/Cilastatin can disrupt gut bacteria and allow Clostridioides difficile (C. diff) to overgrow, causing severe diarrhea, abdominal cramps, and fever. This can occur during treatment or up to two months after finishing the antibiotic. Watery, bloody, or unusually foul-smelling diarrhea warrants an immediate call to your doctor.

• Severe allergic reaction (anaphylaxis): Symptoms include hives, throat tightening, difficulty breathing, rapid heartbeat, or a sudden drop in blood pressure. If you've had an allergic reaction to penicillin, cephalosporins, or other carbapenems, tell your doctor before starting Imipenem/Cilastatin — there is a small chance of cross-reaction (~1–2%). Call 911 immediately if you experience breathing difficulty or throat swelling.

• Confusion, disorientation, or behavioral changes: Central nervous system side effects including confusion, hallucinations, and encephalopathy have been reported, particularly in elderly patients or those with impaired kidney function. These are serious and require immediate medical evaluation.

• Jaundice or dark urine: Rarely, cholestatic hepatitis can occur during or within 1–3 weeks of completing Imipenem/Cilastatin therapy. Yellow skin or eyes, dark urine, or pale stools require prompt evaluation.

• Skin rash: A mild rash can be a drug reaction. However, a severe blistering rash spreading to mucous membranes may indicate Stevens-Johnson syndrome — a rare but life-threatening skin reaction. Stop the drug and seek emergency care immediately.

Who Is at Highest Risk for Serious Side Effects?

Certain patients have a higher risk of serious side effects from Imipenem/Cilastatin and require extra monitoring:

• Patients with chronic kidney disease — dose must be reduced to prevent toxic drug levels and seizure risk

• Patients with prior seizure history or brain injury — the seizure threshold may already be lowered

• Elderly patients — reduced kidney function with age increases risk of CNS toxicity

• Patients on valproic acid — carbapenems dramatically reduce valproate levels, risking breakthrough seizures

Lab Monitoring During Treatment

Your medical team will typically monitor:

• Complete blood count (CBC) — to detect blood cell changes

• Comprehensive metabolic panel (CMP) — to monitor kidney and liver function

• Creatinine and BUN — kidney function, which determines correct dosing

• Valproic acid levels — if you are on anti-seizure medications

Questions to Ask Your Doctor Before Starting Treatment

• "Should my dose be adjusted for my kidney function?"

• "I take valproic acid — is it safe to use Imipenem/Cilastatin?"

• "I've had a penicillin allergy — what should I watch for?"

• "What monitoring labs will I need during treatment, and how often?"

If You're Having Trouble Getting Your Imipenem/Cilastatin

During the active shortage, getting your Imipenem/Cilastatin on schedule matters for both safety and effectiveness. If your infusion pharmacy is having supply issues, medfinder can help locate infusion pharmacies with current stock near you. Contact your prescribing physician immediately if you're at risk of missing a dose.